EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study

Khatimya Kudabayeva, Bibigul Tleumagambetova iD, Yerlan Bazargaliyev, Lorina Vudu

Journal of Diabetes Investigation · 2026-06 · 17 (6) · 970-978

DOI: 10.1111/jdi.70312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 21.04.2026. Verfasst von Khatimya Kudabayeva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Diseases № 1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan. Hauptthemen laut MEDLINE: Autoantibodies, Diabetes Mellitus, Type 2, Biomarkers, Islets of Langerhans. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: West Kazakhstan Marat Ospanov Medical University,.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Introduction Type 2 diabetes mellitus (T2DM) is a heterogeneous condition, and a proportion of patients show autoimmune features consistent with latent autoimmune diabetes in adults (LADA). This study assessed the prevalence of islet autoantibodies in newly diagnosed T2DM patients of Kazakh ethnicity. Materials and Methods A cross‐sectional study was conducted in 240 patients (30–75 years) with newly diagnosed T2DM in the Aktobe region, Kazakhstan (May 2024–January 2025). Clinical data, HbA1c, and fasting C‐peptide were measured. Autoantibodies (GADA, ZnT8A, IA‐2A, ICA‐ELISA) were determined by ELISA. Results Overall, 25.8% of patients were positive for at least one islet autoantibody. ZnT8A (13.3%) and GADA (5.8%) were the most frequent, while IA‐2A and ICA‐ELISA were rare (0.8% each). Double positivity was observed in 4.6% of patients, and triple positivity in 0.4%. GADA was associated with lower BMI (kg/m 2 ), higher HbA1c, and reduced C‐peptide, while ZnT8A was linked to lower C‐peptide. Logistic regression confirmed C‐peptide as the main predictor of autoantibody positivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesDiabetes Mellitus, Type 2BiomarkersIslets of LangerhansHumansCross-Sectional StudiesFemaleAdultMaleMiddle AgedAgedKazakhstanZinc Transporter 8Latent Autoimmune Diabetes in AdultsFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

KazakhstanLatent autoimmune diabetes in adultsZnT8A

Substanzen

AutoantibodiesBiomarkersZinc Transporter 8SLC30A8 protein, human

Autor:innen und Institutionen

  • Department of Internal Diseases № 1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.
  • Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Moldova.

ORCID-Profile: Bibigul Tleumagambetova

Förderung

  • West Kazakhstan Marat Ospanov Medical University,

Zitieren

APA

Kudabayeva, K., Tleumagambetova, B., Bazargaliyev, Y., & Vudu, L. (2026). Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study. Journal of Diabetes Investigation, 17(6), 970-978. https://doi.org/10.1111/jdi.70312

Vancouver

Kudabayeva K, Tleumagambetova B, Bazargaliyev Y, Vudu L. Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study. Journal of Diabetes Investigation. 2026;17(6):970-978. doi:10.1111/jdi.70312

BibTeX
@article{Kudabayeva2026,
  author = {Kudabayeva, Khatimya and Tleumagambetova, Bibigul and Bazargaliyev, Yerlan and Vudu, Lorina},
  title = {Frequency of islet autoantibody seropositivity among adults with newly diagnosed type 2 diabetes in the Kazakh population: A cross‐sectional study},
  journal = {Journal of Diabetes Investigation},
  year = {2026},
  volume = {17},
  number = {6},
  pages = {970--978},
  doi = {10.1111/jdi.70312}
}
Kostenlos starten →